|
|
Volumn 38, Issue 4, 2004, Pages 204-211
|
|
Single and combined psychotropic medication use in a child and adolescent mental health service
a
|
|
Author keywords
CAMHS; Combination pharmacotherapy; Prescribing practice
|
|
Indexed keywords
ATYPICAL ANTIPSYCHOTIC AGENT;
BENZATROPINE MESILATE;
BENZODIAZEPINE;
CARBAMAZEPINE;
CENTRAL STIMULANT AGENT;
CHLORPROMAZINE;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
CITALOPRAM;
CLONIDINE;
DEXAMPHETAMINE;
DIAZEPAM;
DOSULEPIN;
FLUOXETINE;
FLUVOXAMINE;
HALOPERIDOL;
IMIPRAMINE;
LITHIUM CARBONATE;
METHYLPHENIDATE;
NEUROLEPTIC AGENT;
OLANZAPINE;
PAROXETINE;
PSYCHOTROPIC AGENT;
RISPERIDONE;
SEROTONIN UPTAKE INHIBITOR;
SERTRALINE;
THIORIDAZINE;
TRICYCLIC ANTIDEPRESSANT AGENT;
UNINDEXED DRUG;
VALPROIC ACID;
VENLAFAXINE;
ADOLESCENT;
ADULT;
ANXIETY DISORDER;
ARTICLE;
ATTENTION DEFICIT DISORDER;
AUTISM;
BEHAVIOR DISORDER;
BORDERLINE STATE;
BRAIN INJURY;
CHILD;
CHILD PSYCHIATRY;
CLINICAL FEATURE;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG INDICATION;
DRUG SAFETY;
DRUG UTILIZATION;
EATING DISORDER;
EXTRAPYRAMIDAL SYMPTOM;
HEALTH PRACTITIONER;
HUMAN;
INSOMNIA;
INTERVIEW;
MAJOR CLINICAL STUDY;
MAJOR DEPRESSION;
MEDICAL AUDIT;
MEDICAL RESEARCH;
MEDICAL STUDENT;
MENTAL DISEASE;
MENTAL HEALTH SERVICE;
MONOTHERAPY;
OBSESSIVE COMPULSIVE DISORDER;
OUTCOMES RESEARCH;
PANIC;
PRESCRIPTION;
PSYCHIATRIC DIAGNOSIS;
PSYCHOSIS;
RISK BENEFIT ANALYSIS;
SEDATION;
SIDE EFFECT;
URBAN AREA;
ADOLESCENT;
CHILD;
CHILD, PRESCHOOL;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
MALE;
MENTAL DISORDERS;
MENTAL HEALTH SERVICES;
PRESCRIPTIONS, DRUG;
PSYCHOTROPIC DRUGS;
|
|
EID: 2342459609
PISSN: 00048674
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1440-1614.2004.01341.x Document Type: Article |
|
Times cited : (8)
|
|
References (17)
|
